Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Hospitalization 93% Improvement Relative Risk Vitamin D for COVID-19  Allami et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 171 patients in Iraq Lower hospitalization with higher vitamin D levels (p<0.000001) c19early.org Allami et al., 1st Samarra Int. Confer.., Nov 2022 Favors vitamin D Favors control

The risk of up normal values of two parameters obesity and vitamin D in incidence of coronavirus disease-19 among Iraqi patients

Allami et al., 1st Samarra International Conference for Pure and Applied Sciences (SICPS2021), doi:10.1063/5.0121166
Nov 2022  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 119 studies, recognized in 7 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19early.org
Retrospective 86 COVID-19 hospitalized patients and 86 healthy controls in Iraq, showing COVID-19 cases associated with severe vitamin D deficiency.
This is the 149th of 192 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 611 vigintillion).
risk of hospitalization, 92.5% lower, OR 0.07, p < 0.001, high D levels (≥10ng/mL) 91, low D levels (<10ng/mL) 80, adjusted per study, inverted to make OR<1 favor high D levels (≥10ng/mL), case control OR, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Allami et al., 8 Nov 2022, retrospective, Iraq, peer-reviewed, 6 authors. Contact: ahmed.suleiman@uoanbar.edu.iq.
This PaperVitamin DAll
The Risk of Up Normal Values of Two Parameters Obesity and Vitamin D in Incidence of Coronavirus Disease-19 Among Iraqi Patients
Risala H Allami, Ahmed A Suleiman, Raghad S Mouhamad, Maha H Abdullah, Mustafa Y Alsudani, Ali H Adhiah
The new epidemic of coronavirus disease-19 outbreak has caused rapid morbidity and mortality rates worldwide, and health parameters have been proposed to influence disease progression. Among these parameters are index of body mass (BMI) and D vitamin. 86 patients with same number of control were studied( case-control) to find the relationship between the BMI, vitamin D and risk of COVID-19. Vitamin D (25-hydroxyvitamin D) serum level was estimated by ELISA. Results revealed that the age mean value was elevated significantly in cases compared to normal persons , and 50% of patients were 50 years of age or older. patients BMI were higher significantly in comparison with controls, and most of patients were overweight/obese (76.7%). The Vitamin D level decreased in patients significantly compared to control, and most of patients were severely-deficient (75.6%). Logistic-regression-analysis depicted a high risk of COVID-19 in obese cases (OR= 26.39; 95% interval of confidence [CI]: 7.02-99.24; p < 0.001), and in patients with severe deficient in vitamin D (OR = 13.34; 95% CI: 6.32-28.19; < 0.001). Moreover, overweight/obese patients severely deficient in vitamin D were at high risk of developing COVID-19 infection (OR = 230.55; 95% CI: 43.98-1208.67; p < 0.001). Curve analysis of ROC(Receiver-operating-characteristic) showed that BMI and vitamin D occupied under curve significant area (0.770 and 0.864, respectively). In conclusions, the study indicated that individuals who were overweight/obese and severely deficient in vitamin D were more susceptible to develop COVID-19.
References
Ali, None, J. Infect. Public Health, doi:10.1016/j.jiph.2020.06.021
Amiri, Behnezhad, Hasani, None, Obes. Med, doi:10.1016/j.obmed.2020.100196
Annweiler, Cao, Sabatier, None, Maturitas, doi:10.1016/j.maturitas.2020.06.003
De Heredia, Gómez-Martínez, Marcos, None, CUP
Ge, Wang, Yuan, Xiao, Wang et al., None, Eur. J. Clin. Microbiol. Infect. Dis, doi:10.1007/s10096-020-03874-z
Gombart, None, Future Microbiol
Hegde, Dhurandhar, None, Clin. Microbiol. Infect
Holick, None, Rev. Endocr. Metab. Disord, doi:10.1007/s11154-017-9424-1
Hussain, Mahawar, Xia, Yang, El-Hasani, None, Obes. Res. Clin. Pract, doi:10.1016/j.orcp.2020.07.002
Kennel, Drake, Hurley, None, Mayo Clin. Proc
Kościuczuk, Lisowski, Jarczak, Strzałkowska, Jóźwik et al., None, Mol. Biol. Rep
Lee, None, Best Pract. Res. Clin. Endocrinol. Metab, doi:10.1016/j.beem.2011.03.001
Lisowski, Jarczak, Strzałkowska, Jóźwik, Horbańczuk et al., None, Mol. Biol. Rep
Liu, Zhang, Li, Li, Zhou et al., None, J. Clin. Virol
Maresova, Javanmardi, Barakovic, Barakovic, Husic et al., None, BMC Public Health, doi:10.1186/s12889-019-7762-5
Montecino-Rodriguez, Berent-Maoz, Dorshkind, None, J. Clin. Invest
Muscogiuri, Pugliese, Barrea, Savastano, Colao, None, Metabolism, doi:10.1016/j.metabol.2020.154251
Nuttall, None, Nutr. Today, doi:10.1097/NT.0000000000000092
O'shea, Corrigan, Dunne, Jackson, Woods et al., None, Int. J. Obes, doi:10.1038/ijo.2013.16
Palacios, Gonzalez, None, J. Steroid Biochem. Mol. Biol, doi:10.1016/j.jsbmb.2013.11.003
Pan, Liu, Wang, Guo, Hao et al., None, JAMA -J. Am. Med. Assoc, doi:10.1001/jama.2020.6130
Peng, None, Biomed. Pharmacother, doi:10.1016/j.biopha.2020.110499
Prietl, Treiber, Pieber, Amrein, None, Nutrients, doi:10.3390/nu5072502
Quesada-Gomez, Castillo, Bouillon, None, J. Steroid Biochem. Mol. Biol, doi:10.1016/j.jsbmb.2020.105719
Rojas-Osornio, Cruz-Hernández, Drago-Serrano, Campos-Rodríguez, None, Obes. Res. Clin. Pract, doi:10.1016/j.orcp.2019.05.003
Tamara, Tahapary, None, Diabetes Metab. Syndr. Clin. Res. Rev, doi:10.1016/j.dsx.2020.05.020
Wilder-Smith, Chiew, Lee, None, Lancet Infect. Dis, doi:10.1016/S1473-3099(20)30129-8
Yang, Liu, Zhang, Li, Li et al., None, J. Clin. Virol, doi:10.1016/j.jcv.2020.104475
Yegorov, Bromage, Boldbaatar, Ganmaa, None, Front. Nutr, doi:10.3389/fnut.2019.00166
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit